← Back to Search

Antibiotic

Doxycycline Hcl for COVID-19

Phase 1
Waitlist Available
Research Sponsored by ProgenaBiome
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months

Summary

In this trial patients will be treated with either a combination of therapies to treat COVID-19 or a placebo. Treatment will last 10 days, and patients will be followed for 6 months.

Eligible Conditions
  • COVID-19
  • Coronavirus
  • Coronavirus Disease

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Efficacy of Treatment as measured by RT-PCR
Efficacy of Treatment as measured by Titer
Time to Non-Infectivity by RT-PCR
+2 more
Secondary study objectives
Safety of Treatment as Measured by C-Reactive Protein
Safety of Treatment as Measured by Complete Blood Count
Safety of Treatment as Measured by D-Dimer
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Active ArmExperimental Treatment5 Interventions
Patients will be treated with a combination of Ivermectin, Doxycycline, Zinc, Vitamin D3 and Vitamin C
Group II: PlaceboPlacebo Group3 Interventions
Placebo and Vitamin D3, Vitamin C, and Zinc
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Vitamin D3
2011
Completed Phase 4
~3590
Vitamin C
2017
Completed Phase 4
~18470
Ivermectin
2016
Completed Phase 4
~36480
Doxycycline Hcl
2011
Completed Phase 2
~60
Zinc
2005
Completed Phase 4
~16490

Find a Location

Who is running the clinical trial?

ProgenaBiomeLead Sponsor
45 Previous Clinical Trials
5,319 Total Patients Enrolled
6 Trials studying COVID-19
1,268 Patients Enrolled for COVID-19
Topelia TherapeuticsUNKNOWN
Sabine Hazan, MDStudy DirectorProgenaBiome
40 Previous Clinical Trials
4,998 Total Patients Enrolled
6 Trials studying COVID-19
1,268 Patients Enrolled for COVID-19
~6 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top